A9269 Programmable Transient Oral Capsule Reimbursement

HCPCS Level II code A9269 represents a programmable, transient, orally ingested capsule designed for use with an external programmer and billed on a monthly basis. This device-level code captures a growing category of ingestible, externally controlled therapeutic or diagnostic capsules that enable device functionality without permanent implantation. Nationally, such codes matter because they affect coverage decisions, DME/medical device reimbursement pathways, and provider billing practices for novel ingestible technologies.

Key payers in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of what the code covers, the expected service type and sites of service, and what to watch for in payer coverage patterns and billing execution. The publication outlines benchmarks for coding and billing adoption, common modifier usage (listed elsewhere in the publication), and the clinical context in which an externally programmed ingestible capsule would be used.

The analysis also flags areas where payer policy language and prior authorization requirements commonly influence utilization and reimbursement. Where available, the report summarizes national payer approaches and highlights operational considerations for billing teams and revenue cycle staff. Data not available in the input is identified explicitly in the detailed sections.

Billing Code Overview

HCPCS Level II code A9269 describes a programmable, transient, orally ingested capsule intended for use with an external programmer, billed per month. The device is designed to be ingested and function transiently while programmers or controllers external to the body manage its operation.

Service type: Durable medical device / implantable/ingestible therapeutic device (programmable transient oral capsule).

Typical site of service: Outpatient clinic, ambulatory care setting, or other settings where the external programmer is available and device use is monitored, with the capsule ingested by the patient and programming managed externally.

Clinical Context

A typical patient is an adult with refractory gastrointestinal bleeding or chronic iron deficiency anemia despite oral iron supplements, being evaluated for a programmable, transient, orally ingested capsule used with an external programmer on a monthly basis. The device is prescribed by a gastroenterologist or hematologist after prior therapies and diagnostic evaluations (endoscopy, colonoscopy, laboratory iron studies) have failed to control bleeding or correct anemia. The capsule is swallowed in clinic or at home and remains transiently active in the gastrointestinal tract; the external programmer is used to adjust or interrogate the capsule settings and to confirm functionality. Billing for A9269 is per month and may be associated with scheduled monthly device replacement or subscription services. Typical workflow: patient visit for device counseling and informed consent; swallowing of the capsule in clinic or at home with documented administration; external programmer session in clinic to verify capsule activation and record device data; follow-up visits or remote monitoring monthly; documentation includes device model, serial number, date of ingestion, programming parameters, patient tolerance, and clinical response.

Coding Specifications

Modifier	Description	When to Use
`22`	Increased procedural services	Use when work required to provide the device-related service is substantially greater than typical and documentation supports the increased work.

Taxonomy Code	Specialty	Notes
`207RC0000X`	Gastroenterology	Primary specialty prescribing and managing GI-related capsule therapies and monitoring for bleeding or anemia.
`207RH0000X`	Hematology	Manages anemia evaluation and indications for device-based therapies when iron-deficiency or chronic bleeding is present.
`363L00000X`	Infectious Disease / Device Management	Consulted for device-related infection concerns or complex device management (select centers).
`208D00000X`	General Surgery	In centers where surgical oversight or alternative placement is required; limited role for an oral transient capsule.
`208000000X`	Family Medicine	May coordinate outpatient device administration and monthly follow-up in primary care settings.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`K92.2`	Gastrointestinal hemorrhage, unspecified	Common indication when a programmable ingestible capsule is used to localize, monitor, or manage GI bleeding episodes.
`D50.9`	Iron deficiency anemia, unspecified	Frequent clinical reason for device use when oral supplementation and standard treatments have failed to correct anemia.
`K92.1`	Melena	Relevant for patients with overt upper GI bleeding where capsule monitoring or evaluation is considered.
`K50.90`	Crohn's disease, unspecified, without complications	Inflammatory bowel disease patients may require capsule monitoring for bleeding or mucosal disease activity.
`K51.90`	Ulcerative colitis, unspecified, without complications	Another IBD diagnosis where capsule monitoring helps assess mucosal bleeding or disease extent.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`43239`	Esophagogastroduodenoscopy, flexible, transoral; with tumor ablation, any method	May be performed before capsule therapy to evaluate and treat active upper GI bleeding sources prior to capsule administration.
`45380`	Colonoscopy, flexible; with biopsy, single or multiple	Used to evaluate colonic sources of bleeding before device use and may precede prescription of the capsule.
`91040`	Gastrointestinal transit study, capsule retention evaluation and interpretation	Related diagnostic study to assess capsule transit or retention when evaluating device function or complications.
`99457`	Remote physiologic monitoring treatment management services, clinical staff/physician/other qualified health care professional time in a calendar month, requiring interactive communication with the patient/caregiver	Used for monthly remote monitoring or programming follow-up associated with the device when interactive management is provided.
`99090`	Analysis and interpretation of device data, documentation, and report	Applied when the external programmer data is analyzed and billed separately per payer policy as a professional service.

OpenPayer

Summary & Overview

HCPCS A9269: Programmable Transient Orally Ingested Capsule, Monthly